tiprankstipranks
Trending News
More News >
Arecor Therapeutics PLC (GB:AREC)
LSE:AREC
UK Market

Arecor Therapeutics PLC (AREC) Income Statement

Compare
3 Followers

Arecor Therapeutics PLC Income Statement

Last quarter (Q4 2024), Arecor Therapeutics PLC's total revenue was £3.06M, an increase of 78.83% from the same quarter last year. In Q4, Arecor Therapeutics PLC's net income was £-5.60M. See Arecor Therapeutics PLC’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
£ 5.05M£ 4.57M£ 2.40M£ 1.16M£ 1.70M
Gross Profit
£ 1.54M£ 4.57M£ 2.06M£ 1.16M£ 1.70M
Operating Expenses
£ 12.24M£ 13.75M£ 13.03M£ 7.13M£ 5.13M
Depreciation and Amortization
£ 446.00K£ 496.00K£ 341.00K£ 171.00K£ 168.00K
EBITDA
£ -10.15M£ -8.39M£ -10.06M£ -6.27M£ -3.26M
Operating Income
£ -10.70M£ -9.18M£ -10.63M£ -5.98M£ -3.43M
Other Income/Expenses
£ 79.00K£ 274.00K£ 88.00K£ -506.00K£ -84.00K
Pretax Income
£ -10.62M£ -8.90M£ -10.54M£ -6.95M£ -3.51M
Net Income
£ -10.24M£ -8.55M£ -9.26M£ -6.17M£ -2.75M
Per Share Metrics
Basic EPS
£ -0.33£ -0.28£ -0.32£ -0.27£ -0.10
Diluted EPS
£ -0.33£ -0.28£ -0.32£ -0.27£ -0.10
Weighted Average Shares Outstanding
33.44M 30.62M 28.94M 23.03M 27.68M
Weighted Average Shares Outstanding (Diluted)
33.44M 30.62M 28.94M 23.03M 27.68M
Currency in GBP

Arecor Therapeutics PLC Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis